{"id":"W4403058047","doi":"10.1055/s-0044-1789693","title":"Efficacy of mirikizumab in patients with moderate-to-severe Crohn’s disease in comparison to ustekinumab: Summary results from the double-blind Phase 3 VIVID-1 trial","year":2024,"lang":"en","type":"article","venue":"Zeitschrift für Gastroenterologie","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"","keywords":"Ustekinumab; Crohn's disease; Double blind; Medicine; Internal medicine; Phase (matter); Disease; Dermatology; Placebo; Pathology; Physics; Alternative medicine; Infliximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717829,0.001437247,0.00407643,0.0002830377,0.0003149375,0.001089897,0.0006442892,0.001256809,0.00290023],"category_scores_gemma":[0.00138045,0.0005489407,0.002423963,0.0002996966,0.0007215257,0.001117802,0.0003077592,0.003227451,0.0005969085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004476656,"about_ca_system_score_gemma":0.0005342537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004743073,"about_ca_topic_score_gemma":0.001064892,"domain_scores_codex":[0.9994569,0.0003005698,0.00003658527,0.00007747428,0.00003858426,0.00008980868],"domain_scores_gemma":[0.9993221,0.0002315017,0.0001695419,0.00004476623,0.00003182179,0.0002003998],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9517942,0.001865607,0.0009690113,0.001527325,0.002831543,0.00005513365,0.00006355412,0.0005503192,0.005327119,0.0001369872,0.001448294,0.03343094],"study_design_scores_gemma":[0.924647,0.05976137,0.009720083,0.0001167475,0.002363513,0.0001208981,0.00004686655,0.0007305206,0.0008503117,0.0002884278,0.001316786,0.00003757571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9566651,0.03567895,0.0008395669,0.001461088,0.0008421088,0.0005951178,0.001162168,0.0002201287,0.002535904],"genre_scores_gemma":[0.9828809,0.01013685,0.001084002,0.001221244,0.0005907924,0.0005937461,0.001415465,0.00004317268,0.002033796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00407643,"threshold_uncertainty_score":0.009702265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0258404374694007,"score_gpt":0.3115402854947364,"score_spread":0.2856998480253357,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}